The Prevalence of Insomnia in Patients With Psychiatric Disorders

NCT05408013 | Recruiting

• 1 other identifier: (ID 2020-01992)
• Study Type: observational
• Target: 500
• Locations: 1 country
• Sites: 1

Brief Summary

The primary aim of the proposed project is to investigate the prevalence of insomnia in patients with psychiatric disorders treated as inpatients in psychiatric hospitals in two study sites in Switzerland and nine study sites in Germany. The secondary aim is to investigate whether there are demographic or disorder specific parameters that influence the prevalence of insomnia in patients with psychiatric disorders.

Conditions

Insomnia

Outcome Measures

Primary Outcomes (1)

• Insomnia Disorder

  The prevalence of insomnia disorder will be assessed at a one-time point per patient during a study session with a clinician.

  Day 1

Study Arms (1)

ward patients in psychiatric hospitals

Patients in psychiatric hospitals will be assessed so that the prevalence of insomnia in psychiatric inpatients can be estimated.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients who suffer from a psychiatric disorder according to the DSM-5 and who are currently treated as inpatients in a psychiatric hospital

You may qualify if:

• patients who suffer from a psychiatric disorder according to the DSM-5 and who are currently treated as inpatients in one of these psychiatric hospitals:
• swiss study sites: Universitäre Psychiatrische Dienste in Bern, Privatklinik Meiringen.
• german study sites: Freiburg, Ingolsatdt, Kiel, Klingenmünster, Leipzig, Mannheim, Nürnberg, Paderborn, Regensburg

You may not qualify if:

• Age under 18 years
• involuntary stay at the clinic
• unable to give informed consent

Sponsors & Collaborators

• University of Bern: lead
• Universitätsklinikum Freiburg Klinik für Psychiatrie und Psychotherapie: collaborator
• Universitätsklinikum Schleswig-Holstein Klinik für Psychiatrie und Psychotherapie: collaborator
• Schlafzentrum Pfalzklinikum Klingenmünster: collaborator
• Klinik und Poliklinik für Psychiatrie und Psychotherapie Leipzig: collaborator
• Zentralinstitut für Seelische Gesundheit Mannheim: collaborator
• Privatklinik Meiringen: collaborator
• Universitätsklinik für Psychiatrie und Psychotherapie, PMU Nürnberg: collaborator
• LWL-Klinik Paderborn: collaborator
• Klinik für Psychiatrie und Psychotherapie der Universität Regensburg: collaborator
• Kompetenzzentrum Schlafmedizin Charité - Campus Benjamin Franklin: collaborator
• Klinikum Ingolstadt (withdrawal of participation): collaborator

Study Sites (1)

Universitäre Psychiatrische Dienste Bern (Upd)

Bern, 3000 60, Switzerland

RECRUITING

Related Publications (1)

• Seow LSE, Verma SK, Mok YM, Kumar S, Chang S, Satghare P, Hombali A, Vaingankar J, Chong SA, Subramaniam M. Evaluating DSM-5 Insomnia Disorder and the Treatment of Sleep Problems in a Psychiatric Population. J Clin Sleep Med. 2018 Feb 15;14(2):237-244. doi: 10.5664/jcsm.6942.

  PMID: 29394962 BACKGROUND

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, Intrinsic; Dyssomnias; Sleep Wake Disorders; Nervous System Diseases; Mental Disorders

Study Officials

• Christoph Nissen, Prof. Dr. med

  Sleep Research in Psychiatry

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Christoph Nissen, Prof. Dr. med

CONTACT

+ 41 (0)31 930 9111; christoph.nissen@upd.ch

Elisabeth Hertenstein, Dr. phil

CONTACT

+41 (0)31 930 9502; elisabeth.hertenstein@upd.ch

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Prof. Dr. med.

Study Record Dates

• First Submitted: October 28, 2021
• First Posted: June 7, 2022
• Study Start: July 1, 2021
• Primary Completion: March 31, 2025
• Study Completion: March 31, 2025
• Last Updated: May 8, 2024

Record last verified: 2024-05

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, ICF
• Time Frame: In the end of the study the coded data will be sent to Berlin and used for result calculations
• Access Criteria: Encrypted data will be sent via secure mails to heidi.danker-hopfe@charite.de. The code to open the encrypted data will be sent via a separate mail. The methods are conform with the regulations of the ethics commission of Switzerland and Germany.

Locations

CH (1)